A Study of Oral Calcitonin Given at Night to Healthy Postmenopausal Women
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to assess the plasma CTx-1 concentrations when dosing is at
night and to compare these results with those obtained with a placebo control and with
commercially available nasal calcitonin.